The main criticism is certainly the most, that a major construction site remains open. And these are the regional differences in fees and the dislocations in the fees of individual disciplines. Here, many doctors expected that the fees be compensated respectively increased. Mr Hantschke: At the pharmacists she situation as follows: the most pharmacists feel the economic effects of the medicines market rebalancing Act, the AMNOG which entered into force before half a year. Therefore, especially large companies try to relieve the cost side.
You negotiate with wholesale prices and conditions, for example, increase the direct reference rate or reduce staff. At the same time, they try but also to increase the revenue per visitor of Pharmacy – E.g. more intensive marketing efforts, training of personnel, additional sales. Editor: we come to the topics of regional supply and the Praxensterben; how serious is the situation really? Mr Hafeez: the fact is that until 2020 less than 50,000 specialists and House – age will leave their approval. At the same time, the supply demand, because our Society is getting older. Putting this practice output shaft now perspective in relation to the potential and the preferences of medical scientists, so in fact already a shortage of doctors is emerging.
It concerns not only the eastern part of Germany, as it is widely believed. In the North German Lander more than 200 primary care physicians have been lacking for example already in February 2011. Click Jeffrey Leiden for additional related pages. You must counteract this of course. Mr Jansen: Here also the planned public supply structure Act (GKV LSG) will apply. It should establish the conditions that potential successors in particular in rural regions will find attractive conditions. This new supply, gear cutters and compensation arrangements are under discussion. I think that this is a very useful approach. But also in principle: an entrepreneurial spirit guided, successful practice will usually have a successor.